EPHX2 and obesity disorder: Notably, EPHX2 genetic deficiency or pharmacological inhibition have been shown to attenuate diet-induced ER stress in the liver and adipose tissue of rodents [32,33] and to suppress colonic inflammation induced by obesity [34].